Rapid ICH

by RapidAI  · Based in United States → — Clinical AI Platform Enhancing Assessment & Care
Emergency Medicine Neurology Radiology

Contact for pricing
Regulatory Status Disclosed

Overview

Rapid ICH, part of the comprehensive RapidAI platform, is an artificial intelligence-powered software designed to quickly detect and triage suspected intracranial hemorrhage (ICH) on non-contrast computed tomography (NCCT) scans. It plays a crucial role in the acute assessment of patients presenting with neurological symptoms, particularly in stroke care. The software automatically processes images from a scanner, identifies various types of acute hemorrhages including intraparenchymal (IPH), intraventricular (IVH), subdural (SDH), and subarachnoid (SAH), and quantifies their volume, often down to 0.4 mL.

Rapid ICH provides immediate notifications to clinicians via PACS diagnostic workstations, email, and the Rapid Mobile app, streamlining workflow and accelerating critical treatment and transfer decisions. Developed using machine learning and deep learning techniques, it boasts high sensitivity and specificity for ICH detection, aiming to reduce missed hemorrhages and improve patient outcomes. The platform is designed to assist hospital networks and trained radiologists in workflow triage, complementing clinical judgment rather than replacing it.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated detection of suspected intracranial hemorrhage (ICH) on NCCT scans
  • Triage and rapid notification of suspected ICH cases
  • Detection of various hemorrhage subtypes (IPH, IVH, SDH, SAH)
  • Quantification of hemorrhage volume (down to 0.4 mL or 1 mL)
  • High sensitivity (e.g., 98.1-97%) and specificity (e.g., 99.7-100%) for ICH detection
  • Rapid image processing and notification (within minutes, often under 60 seconds)
  • Notifications delivered via PACS, email, and Rapid Mobile app
  • AI/Machine Learning powered analysis using convolutional neural networks
  • Prioritizes cases within the radiology worklist
  • Integration with the broader RapidAI platform for comprehensive stroke assessment

Use Cases

  • Expedited diagnosis of intracranial hemorrhage in acute neurological emergencies
  • Triage and prioritization of stroke patients in emergency departments and mobile stroke units
  • Assisting physicians in making timely treatment and transfer decisions for hemorrhagic stroke
  • Reducing the rate of missed hemorrhages in clinical routine
  • Streamlining workflow and communication for stroke care teams
  • Supporting Joint Commission ICH score compliance through automated volume measurement

What Physicians Need to Know

Stroke Detection Speed
Rapid ICH processes CT head scans in less than a minute. It can notify clinicians of suspected intracranial hemorrhage (ICH) within minutes of receiving the scan. Some studies indicate notifications can be sent in a minute or less.
Brain MRI/CT Analysis
Rapid ICH analyzes non-contrast CT (NCCT) images to detect suspected intracranial hemorrhage. It can identify intraparenchymal, intraventricular, subdural, and subarachnoid hemorrhages. The software can also quantify hemorrhage volume, with measurements down to 1 mL. Rapid ICH has shown high sensitivity (97.84% to 98.1%) and specificity (99.52% to 99.7%) for ICH detection in various studies.
Large Vessel Occlusion Detection
While Rapid ICH focuses on intracranial hemorrhage, the broader RapidAI platform includes other modules like Rapid LVO and Rapid NCCT Stroke that are designed for large vessel occlusion (LVO) detection. Rapid NCCT Stroke, which integrates multiple findings from NCCT, demonstrated sensitivities of 63.5% and specificities of 95.1% for LVO detection.
Triage Prioritization Speed
Rapid ICH is designed to expedite ICH diagnosis and streamline triage and transfer decisions. It automatically screens CT scans for ICH immediately after acquisition. The system can prioritize cases within the radiology worklist and send notifications of suspected ICH to clinicians. Studies suggest AI-based ICH notifications can significantly reduce turnaround time for newly identified hemorrhages.
ASPECTS Score Automation
RapidAI offers a separate module called Rapid ASPECTS, which automatically generates a standardized ASPECT score based on machine-learning algorithms to indicate early signs of brain infarction on non-contrast CT scans. This helps physicians assess ischemic stroke severity and determine thrombectomy eligibility. Rapid ASPECTS has been shown to improve the accuracy of ASPECT score calculation, especially for less experienced readers.
Mobile Notification System
Rapid ICH automatically sends notifications of suspected ICH to PACS, email, and the Rapid mobile app.
Physician Tip

Rapid ICH assists in the rapid detection and volumetric quantification of intracranial hemorrhages on non-contrast CT scans, which is crucial for timely intervention in stroke and head trauma cases. The high sensitivity and specificity of the tool, combined with its ability to process scans in under a minute, can significantly expedite diagnosis and treatment decisions. The system's mobile notification capabilities ensure that critical information reaches care teams promptly, facilitating faster triage and transfer. Additionally, the integration with Rapid Hyperdensity allows for further quantification and characterization of hyperdense regions, providing more context for managing intracranial hemorrhage. Physicians should be aware that while Rapid ICH is highly accurate, real-world performance can vary, and it should be used as a tool to support clinical decision-making rather than replacing expert interpretation.

Rapid ICH is deployed within the existing Rapid platform and integrates with Picture Archiving and Communication Systems (PACS), email, and the Rapid mobile app for immediate communication of findings. The Rapid Enterprise™ Platform also allows access to trusted partner AI.

Details

Category Neurology AI, Radiology & Imaging AI, Triage & ER/ICU AI
Pricing Contact for pricing
Mobile App1
Compliance
BAA AvailableUnknown AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Emergency Medicine, Neurology, Radiology

Support & Reliability

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2022-09-12K221456 510(k)Rapid ICH

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Rapid ICH

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Rapid ICH.

View all on YouTube

Frequently Asked Questions

Rapid ICH uses artificial intelligence to quickly analyze non-contrast CT scans for suspected intracranial hemorrhage (ICH), including intraparenchymal, intraventricular, subdural, and subarachnoid hemorrhages. It then notifies clinicians of possible hemorrhage, quantifies the volume of hyperdense regions, and helps prioritize cases within the radiology worklist. This aims to streamline decision-making and accelerate patient care by providing rapid insights to care teams.
Rapid ICH has demonstrated high accuracy in detecting ICH, with reported sensitivities ranging from 95.6% to 98.1% and specificities from 95.3% to 99.7%. It can detect hemorrhages as small as 0.4 mL. While highly effective, very small hemorrhages (under 1.5 mL) have been noted as potential false-negative cases in some studies.
Rapid ICH has received FDA 510(k) clearance, indicating it meets the regulatory requirements for medical devices in the United States. The software also supports Joint Commission ICH score compliance by providing measurements for hematoma expansion.
While Rapid ICH offers an AI-powered solution for rapid detection and quantification, other AI models and deep learning-based approaches have been developed for ICH detection on non-contrast CT scans, showing similar strong results in sensitivity and specificity. Traditionally, diagnosis relies on expert interpretation of non-contrast CT scans, which is essential for differentiating ICH from ischemic stroke.
Pricing for Rapid ICH is generally unconfirmed and requires direct contact with the vendor for a custom quote, as it can vary by country and specific hospital needs. Rapid ICH is deployed on Rapid servers within the existing Rapid platform and integrates with hospital systems by sending notifications to PACS, email, and the Rapid mobile app, typically processing scans in under a minute.

Related Tools

syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
Neurophet AQUA AD Plus
Neurophet
Neurology AI
Neurophet AQUA AD Plus is an AI-powered brain imaging analysis software that supports the diagnosis, treatment guidance, and monitoring of Alzheimer's disease by analyzing MRI and PET scans.
myosmart trial kit
Otto Bock Healthcare Products GmbH
Neurology AI
The Ottobock MyoSmart Trial Kit assists clinicians in assessing and fitting advanced neurorehabilitation prosthetic and orthotic solutions.
connectgrip. (560X27-1)
Otto Bock Healthcare Products GmbH
Neurology AI
Otto Bock Healthcare Products GmbH offers advanced prosthetic and orthotic solutions, with 'connectgrip' (560X27-1) likely being a component designed for secure and functional connection within these systems, potentially incorporating intelligent features for enhanced user control.
myosmart.cuff (757M20-2)
Otto Bock Healthcare Products GmbH
Lab & Diagnostics
The myosmart.cuff is a medical device by Otto Bock Healthcare Products GmbH designed for objective measurement of muscle tone, primarily for use in neurological rehabilitation.
myosmart. (13E522)
Otto Bock Healthcare Products GmbH
Neurology AI
myosmart.

See all Neurology AI tools →

More from RapidAI

Rapid ASPECTS
RapidAI
Neurology AI
Rapid ASPECTS provides an automated, standardized ASPECTS score from non-contrast CT scans to quantify early ischemic changes and aid in determining thrombectomy eligibility for stroke patients.
Rapid Enterprise Platform
RapidAI
Cardiology AI

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-08 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.